Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 200-875-0 | CAS number: 75-50-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Health surveillance data
Administrative data
- Endpoint:
- health surveillance data
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Study period:
- 1977
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Acceptable well-documented publication, which meets basic scientific principles
Data source
Reference
- Reference Type:
- publication
- Title:
- Toxicity of aliphatic amines in Uremia
- Author:
- Simenhoff, M.L., Ginn, H. E., and Teschan, P.E.
- Year:
- 1 977
- Bibliographic source:
- Trans.Am.Soc.Artif.INtern.Organs, 1988 Vol. XXIII p. 560 - 64
Materials and methods
- Study type:
- biological effect monitoring
- Endpoint addressed:
- other: Crossing of the Brain-Bloow-Barrier
- Principles of method if other than guideline:
- Some years ago it was found that amines, especially dimethylamine (DMA) and ethanolamine were raised in the blood, CSF and brain of uremic patients. We have always believed that since many of the major uremic symptoms reflecting toxicity are neurologic, these toxic substances must cross the blood brain barrier. Thus, we were concerned with the findings of Wootten and Hicks some years ago when they reported the large variety of phenolic and other organic acids isolated from dialysate, because they did not cross the B-B-B in significant quantity.
- GLP compliance:
- no
Test material
- Reference substance name:
- Trimethylamine
- EC Number:
- 200-875-0
- EC Name:
- Trimethylamine
- Cas Number:
- 75-50-3
- Molecular formula:
- C3H9N
- IUPAC Name:
- N,N-dimethylmethanamine
- Details on test material:
- no data
Constituent 1
Method
- Ethical approval:
- not specified
- Details on study design:
- Twenty-six patients with end-stage kidney disease (most of them on dialysis) had predialysis choice reaction time (CRT) and electroencephalograms (EEG) performed at the Vanderbilt Medical Center. At the same time a serum sample was obtained, and a total of 53 samples were subsequently measured for DMA and TMA. The results of the neurophysiological tests were not known at the time of blood amine determinations. The methods used for serum amine determinations have been previously described. Neurophysiological tests were done according to the method of Ginn and Teschan.
Results and discussion
- Results:
- There is an excellent correlation between the predialysis creatinine and CRT with a p value < 0.001 (Figure 1), whereas there is a poor correlation with the EEG as shown in Figure 2 (p < 0. 50). Serum DMA also correlates better with CRT with a p value < 0. 01 (Figure 3). The relationship of TMA to CRT and EEG gave p value of < 0. 001 and < 0. 003, respectively. The DMA and TMA levels show a statistically significant correlation with both CRT and EEG suggesting that these compounds produce more diffuse and toxic neurologic consequences.
Any other information on results incl. tables
Amine levels above 200 µg % are usually associated with symptoms. Should these toxic effects be confirmed, the metabolic sources of amines would become important. We have previously reported that an abnormal bacterial flora exists high up in the small intestine in advanced renal failure and that alteration of this flora, by nonabsorbable antibiotic administration, reduces blood amine levels with concomitant improvement in symptomatology.
Applicant's summary and conclusion
- Executive summary:
In 1977 Simenhoff et al. investigated the prevalence of DMA and TMA in patients suffering under chronic renal failure. Fifty-three samples in 26 patients were analyzed for aliphatic amines (DMA and TMA), and the levels correlated with 2 neurophysiological tests, choice reaction time (CRT), and electroencephalogram (EEG). A significant correlation was found between TMA and CRT and EEG (p < 0.001 and 0. 003, respectively) and between DMA and CRT (p < 0.01).
These amines reflect part of the spectrum of toxic compounds which accumulate in uremia. Dissociation of neurophysiological functions may be helpful in evaluating various classes of potentially toxic compounds found in renal failure, as exemplified by short-chain aliphatic amines.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.